Cábez A[au] - Search Results

Year	Number of Results
1971	1
2017	1
2018	1
2019	1
2020	2
2021	1
2022	2

1

Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document.

Casellas F, González-Lama Y, Ginard Vicens D, García-López S, Muñoz F, Marín Sánchez L, Camacho L, Cabez A, Fortes P, Gómez S, Bella Castillo P, Barreiro-de Acosta M. Casellas F, et al. Among authors: cabez a. Rev Esp Enferm Dig. 2022 Mar;114(3):156-165. doi: 10.17235/reed.2021.8130/2021. Rev Esp Enferm Dig. 2022. PMID: 34254522 Free article. Review.

2

Consensus document on the management preferences of patients with ulcerative colitis: points to consider and recommendations.

Casellas F, Guinard Vicens D, García-López S, González-Lama Y, Argüelles-Arias F, Barreiro-de Acosta M, Marín Sánchez L, Mendive JM, Saldaña R, Cabez A, Gómez S, Loza E. Casellas F, et al. Among authors: cabez a. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1514-1522. doi: 10.1097/MEG.0000000000001885. Eur J Gastroenterol Hepatol. 2020. PMID: 32804838 Review.

3

Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.

Queiro R, Cañete JD, Montoro M, Gómez S, Cábez A; MAAPS study group. Queiro R, et al. Among authors: cabez a. Arthritis Res Ther. 2020 Apr 15;22(1):82. doi: 10.1186/s13075-020-02168-1. Arthritis Res Ther. 2020. PMID: 32295620 Free PMC article.

4

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

Queiro R, Cañete JD, Montilla C, Abad M, Montoro M, Gómez S, Cábez A; MAAPS study group. Queiro R, et al. Among authors: cabez a. Arthritis Res Ther. 2017 Mar 29;19(1):72. doi: 10.1186/s13075-017-1277-1. Arthritis Res Ther. 2017. PMID: 28356155 Free PMC article.

5

Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain.

Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MÁ, Menchén L. Taxonera C, et al. Among authors: cabez a. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):73-83. doi: 10.1080/14737167.2021.1880324. Epub 2021 Feb 20. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33615953

6

Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study.

Balsa A, Sanmarti R, Rosas J, Martin V, Cabez A, Gómez S, Montoro M. Balsa A, et al. Among authors: cabez a. Rheumatology (Oxford). 2018 Apr 1;57(4):688-693. doi: 10.1093/rheumatology/kex474. Rheumatology (Oxford). 2018. PMID: 29365183

7

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.

Queiro R, Cañete JD, Montilla C, Abad MA, Montoro M, Gómez S, Cábez A; MAAPS Study Group. Queiro R, et al. Among authors: cabez a. J Rheumatol. 2019 Jul;46(7):710-715. doi: 10.3899/jrheum.180460. Epub 2019 Feb 1. J Rheumatol. 2019. PMID: 30709957

8

Dose-response relationship of luteinizing hormone to luteinizing hormone--releasing hormone in man.

Kastin AJ, Schally AV, Gual C, Midgley AR Jr, Miller MC 3rd, Cabez A. Kastin AJ, et al. Among authors: cabez a. J Clin Invest. 1971 Jul;50(7):1551-3. doi: 10.1172/JCI106641. J Clin Invest. 1971. PMID: 4932985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results